ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven Alzheimer's disease risk identification models using ...
Millions of people are diagnosed with Alzheimer’s disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some ...
Researchers have developed artificial intelligence (AI) models that can scrutinize electronic health records (EHR) and electrocardiograms to identify individuals in the general population at elevated ...
Sleep data captured with a wearable device could help clinicians better tailor care by identifying patients with chronic obstructive pulmonary disease (COPD) who may need additional support to ...
Mount Sinai researchers have created an analytic tool using machine learning that can predict cardiovascular disease risk in millions of patients with obstructive sleep apnea, a serious sleep disorder ...
Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without ...
Sportschosun Jang Jong-ho] A study has found that changes in gut microbes may help predict the stage and prognosis of liver ...
ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results